TinyGemsBreaks Archive

TuesdayMar 24, 2026 11:41 am

TinyGemsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Closes $4M Registered Direct Offering Led By Aegis

ParaZero Technologies (NASDAQ: PRZO) announced the closing of its previously announced registered direct offering with a single institutional investor, generating approximately $4 million in gross proceeds through the sale of 5,333,333 ordinary shares and pre-funded warrants at $0.75 per share. The transaction, which closed March 24, 2026, will support general corporate purposes and working capital, with Aegis Capital Corp. acting as exclusive placement agent. To view the full press release, visit https://ibn.fm/gwu2j About ParaZero Technologies ParaZero Technologies Ltd. (Nasdaq: PRZO) is an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry. Founded in 2014 by aviation professionals and drone industry veterans, ParaZero is a…

TuesdayMar 24, 2026 11:17 am

TinyGemsBreaks – Rail Vision Ltd. (NASDAQ: RVSN) Begins Trading On Frankfurt Stock Exchange

Rail Vision (NASDAQ: RVSN) announced that its ordinary shares have begun trading on the Frankfurt Stock Exchange under the symbol C80, while continuing to trade on the Nasdaq Capital Market under RVSN. The company said the dual listing is expected to enhance visibility and trading liquidity in Europe, broaden its investor base and provide expanded access to European institutional and retail investors. To view the full press release, visit https://ibn.fm/gdsiT About Rail Vision Ltd. Rail Vision is a development stage technology company that is seeking to revolutionize railway safety and the data-related market. The company has developed cutting edge, artificial intelligence based, industry-leading technology specifically…

MondayMar 23, 2026 1:29 pm

TinyGemsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Prices $4 Million Registered Direct Offering

ParaZero Technologies (NASDAQ: PRZO) announced it has entered into a definitive agreement for a registered direct offering with a single institutional investor expected to generate approximately $4 million in gross proceeds through the sale of 5,333,333 ordinary shares (or pre-funded warrants) at $0.75 per share. The company said proceeds will be used for general corporate purposes and working capital, with the transaction expected to close on or about March 24, 2026, and Aegis Capital Corp. acting as exclusive placement agent. To view the full press release, visit https://ibn.fm/OkLKo About ParaZero Technologies ParaZero Technologies Ltd. (Nasdaq: PRZO) is an aerospace defense company pioneering smart, autonomous solutions for…

MondayMar 23, 2026 10:10 am

TinyGemsBreaks – Uranium Energy Corp. (NYSE American: UEC) Expands Production Capacity With Wyoming Approvals And Advances U.S. Conversion Facility Plans

Uranium Energy (NYSE American: UEC) announced regulatory approval and startup of three additional header houses at its Christensen Ranch project in Wyoming, supporting increased uranium production capacity, while additional infrastructure remains under construction and pending approval, and its Burke Hollow project in Texas awaits final startup authorization. The company also reported that its subsidiary, United States Uranium Refining & Conversion Corp., received a docket number from the U.S. Nuclear Regulatory Commission for a planned uranium conversion facility, marking a key step in the licensing process as UEC advances its strategy to become a vertically integrated U.S. nuclear fuel supplier. To…

FridayMar 20, 2026 9:40 am

TinyGemsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Signs Strategic Cooperation Agreement With BonV Aero To Expand Counter-UAS Presence In India

ParaZero Technologies (NASDAQ: PRZO) announced the signing of a strategic cooperation agreement with India-based BonV Aero to market its portfolio of counter-UAS solutions, led by the DefendAir system, a mobile, net-based interception platform designed for rapid deployment against hostile drones, while also enabling future configurations and integrations. The companies have already conducted a live demonstration of the portable DefendAir launcher for a key security entity in India, validating its real-world effectiveness and positioning ParaZero to expand its presence in a strategically important market as it explores additional collaboration opportunities across counter-drone applications. To view the full press release, visit https://ibn.fm/maAxq…

TuesdayMar 17, 2026 10:30 am

TinyGemsBreaks – Oragenics Inc. (NYSE American: OGEN) Files 2025 Form 10-K And Provides Operational Update

Oragenics (NYSE American: OGEN) announced the filing of its Annual Report on Form 10-K for the year ended Dec. 31, 2025, alongside a shareholder update highlighting operational, clinical and financial progress. The company reported key 2025 milestones including restored NYSE American compliance, a $16.5 million capital raise, U.S.-based drug manufacturing transition and advancement of its ONP-002 program, while outlining early 2026 progress toward Phase IIa trial initiation in Australia and strategic priorities focused on patient enrollment, U.S. regulatory advancement and expansion of its CNS pipeline. To view the full press release, visit https://ibn.fm/Dg7JA About Oragenics, Inc. Oragenics, Inc. is a…

MondayMar 16, 2026 9:25 am

TinyGemsBreaks – Rail Vision Ltd. (NASDAQ: RVSN) Completes MainLine System Proof of Concept In India

Rail Vision (NASDAQ: RVSN) announced the successful completion of a proof of concept demonstration of its AI-integrated MainLine railway safety system in India following a two-month evaluation conducted under real-world operating conditions with a major local rail operator in collaboration with Sujan Industries. The company said the trial assessed real-time object detection and classification, operational stability and performance across varying environmental conditions, with the customer providing positive feedback and indicating the system is suitable for further evaluation and potential controlled deployment across the Indian railway network. To view the full press release, visit https://ibn.fm/22W4I About Rail Vision Ltd. Rail Vision…

FridayMar 13, 2026 9:50 am

TinyGemsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Receives Counter-UAS Order from Israeli Defense Entity

ParaZero Technologies (NASDAQ: PRZO), an aerospace defense company developing autonomous solutions for the global manned and unmanned aerial systems industry, announced it has received a new purchase order from an Israeli defense entity for its DefendAir counter-unmanned aerial systems platform. The order includes delivery of an evaluation kit featuring DefendAir net pods along with live exercises and training intended to support rapid operational deployment and readiness. The DefendAir system uses patented non-explosive net-launcher technology designed to neutralize hostile drones while minimizing collateral impact and addressing evolving aerial threats across urban and battlefield environments. To view the full press release, visit…

WednesdayMar 11, 2026 9:30 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Launches New Growth Strategy Focused On Neurology And Oncology Pipeline Expansion

CNS Pharmaceuticals (NASDAQ: CNSP) announced a new corporate growth strategy aimed at building a high-value pipeline in neurology and oncology through the acquisition or in-licensing of preclinical and clinical-stage therapeutic assets. Following a comprehensive strategic review incorporating clinical probability-of-success modeling, regulatory pathway analysis and market assessments, the company said it will prioritize programs with differentiated mechanisms, clear development pathways and strong commercial potential, while preparing legacy assets TPI 287 and berubicin for potential out-licensing to focus resources on advancing a new acquisition-driven pipeline. To view the full press release, visit https://ibn.fm/MutVR About CNS Pharmaceuticals, Inc. CNS Pharmaceuticals is a clinical-stage…

TuesdayMar 10, 2026 9:20 am

TinyGemsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents TONMYA Data at International Fibromyalgia Congress

Tonix Pharmaceuticals (NASDAQ: TNXP) announced two oral presentations on TONMYA(TM), investigated as TNX-102 SL (cyclobenzaprine HCl sublingual tablets), at the 8th International Congress on Controversies in Fibromyalgia held March 9-10, 2026, in Krakow, Poland. Post hoc analyses from the Phase 3 RESILIENT trial and pooled data from the RELIEF and RESILIENT studies highlighted rapid pain relief and a favorable benefit-risk profile for TONMYA in adults with fibromyalgia, including statistically significant reductions in pain and a likelihood of clinical benefit nearly four times greater than discontinuation due to adverse events. TONMYA, the first medication approved for fibromyalgia in more than 15…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks